SIRPA and neoplasm: Bian et al. reported that adoptive transfer of SIRPα−/− macrophages, but not anti-CD47 treatment, with RT resulted in durable tumor regression because the macrophages could reverse an the immunosuppressive TME by expressing the M1 phenotype.